CD274 and cancer: To evaluate whether the combined treatment of cancer cells with Cis-Pt and anti-PD-L1 rFab’ may have greater efficacy compared to single treatment, we tested both drugs on cell viability and growth using MTT and clonogenic assays, respectively.